Anti-infective therapy in intensive care units
Related Experiment Videos
1Klinikum der J.-W.-Goethe-Universität, Zentrum der Inneren Medizin/Infektiologie, Frankfurt am Main, Germany.
Abstract:
In intensive care units, treatment is primarily directed at the suspected pathogen. However, the risk of interaction with other concomitantly administered drugs, the possible accumulation when renal and, in particular, hepatic function are impaired, and the possible development of resistance play major roles when selecting a therapeutic regimen. Studies of interactions between the different antimicrobial substances and, in particular, interactions between the antibiotics and other drugs are urgently called for in the future.
Insights
Choosing antimicrobial drugs in intensive care requires careful consideration of drug interactions and potential resistance. Further studies are needed to understand how antibiotics interact with other medications, especially in patients with impaired kidney or liver function.
Area of Science:
- Pharmacology
- Infectious Diseases
- Critical Care Medicine
Background:
- Antimicrobial therapy in intensive care units (ICUs) typically targets suspected pathogens.
- Drug selection is influenced by potential interactions, altered drug metabolism (renal/hepatic impairment), and antimicrobial resistance.
- Current knowledge on drug-drug interactions involving antimicrobials is insufficient.
Purpose of the Study:
- To highlight the critical factors influencing antimicrobial selection in ICUs.
- To emphasize the need for comprehensive studies on drug interactions in critically ill patients.
Main Methods:
- This abstract is a review and does not detail specific experimental methods.
- It synthesizes existing knowledge on antimicrobial selection challenges in ICUs.
Main Results:
- Drug interactions, altered pharmacokinetics due to organ dysfunction, and resistance development are key considerations.
- There is a significant gap in understanding interactions between antimicrobials and other co-administered drugs.
Conclusions:
- Further research into antimicrobial drug interactions is urgently required.
- Such studies are crucial for optimizing therapeutic regimens and improving patient outcomes in ICUs.